BPH care is advancing

BPH care is advancing

With better-informed patients, dialogue becomes a cornerstone of treatment selection.

The treatment selection paradigm in BPH is evolving

Across Europe, millions of men suffer from BPH.1 Therapy has traditionally included pharmaceutical interventions and surgical treatments.2

However, as new options become available and patients seek to be more involved in the decision-making process, is there a need for a shift in the treatment selection paradigm?

“it is important to discuss the whole range of options available to them. We have a duty to do this…
It is our responsibility to encourage a two-way dialogue with our patients to understand the right treatment for them at that given time.”
- Prof. Richard Hindley
The treatment selection  paradigm in BPH is evolving
Watch the full interview here.

A versatile portfolio that can meet your patients’ needs3–9

Decorative Image
While many BPH patients share certain characteristics, each one has a unique set of traits and needs. Each person has hopes and concerns related to the treatment.

Each individual has different priorities in improving their current quality of life.
- Preserve sexual function - Minimise medication  - Reduce risks of surgery - On anticoagulation therapy - Median lobe presence - Prostate volume 30-80 cm3
From water vapor to laser, the versatile therapies of the Boston Scientific BPH portfolio have complementary capabilities.

They also offer technical agility, allowing you to adapt to your patient’s needs and reach a shared treatment decision based on their prostate anatomy and potential clinical comorbidities.

So far, over a million patients have been treated with the Boston Scientific BPH treatment portfolio across clinical trials, observational studies, and clinical practice.5,9–13,17–19

The short hospital stay and overall cost saving provided by our portfolio can also aid in efficient resource management for hospitals.12,14,20,21

Decorative Image